Related Experiment Videos
FAK regulates biological processes important for the pathogenesis of cancer
Veronica Gabarra-Niecko1, Michael D Schaller, Jill M Dunty
1Department of Cell and Developmental Biology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Abstract:
Since its initial discovery as a substrate and binding partner for the Src oncogene, a role for the focal adhesion kinase (FAK) in cancer has been speculated. In this review the clinical evidence correlating FAK overexpression with cancer and the experimental evidence demonstrating that FAK can control some phenotypes associated with cancer will be discussed. In addition, the emerging theme of interactions between the FAK and growth factor signaling pathways will be described. The evidence presented in this review provides a compelling case for a role for FAK in the pathology of human cancer.
Insights
Focal adhesion kinase (FAK) plays a significant role in human cancer development. This review details clinical and experimental evidence linking FAK to cancer pathology and growth factor signaling.
Area of Science:
- Oncology
- Molecular Biology
- Cellular Signaling
Background:
- Focal adhesion kinase (FAK) was initially identified as a substrate and binding partner for the Src oncogene.
- Its involvement in cancer has been a subject of ongoing research and speculation.
- Understanding FAK's role is crucial for cancer research.
Purpose of the Study:
- To review the clinical evidence correlating focal adhesion kinase (FAK) overexpression with various cancers.
- To discuss experimental evidence demonstrating FAK's control over cancer-associated phenotypes.
- To describe the interactions between FAK and growth factor signaling pathways in the context of cancer.
Main Methods:
- Literature review of clinical studies correlating FAK levels with cancer.
- Analysis of experimental data on FAK's functional role in cancer cell phenotypes.
- Examination of research on FAK's crosstalk with growth factor signaling pathways.
Main Results:
- Clinical evidence supports a correlation between FAK overexpression and human cancer.
- Experimental data indicate FAK influences phenotypes critical for cancer progression.
- Emerging evidence highlights significant interactions between FAK and growth factor signaling pathways.
Conclusions:
- The collective evidence strongly implicates focal adhesion kinase (FAK) in the pathology of human cancer.
- FAK represents a potential therapeutic target in oncology.
- Further research into FAK-mediated signaling pathways is warranted for cancer treatment strategies.